Company Overview and News

 
Nikkei rises as easing U.S.-China trade tensions support dollar, exporters

2018-05-21 reuters
TOKYO, May 21 (Reuters) - Japan’s Nikkei share average rose on Monday as the dollars’ rise against the yen supported some exporters after news of easing U.S.-China trade tensions, but weakness in financial stocks kept wider gains limited.

 
Nikkei rises as U.S.-China trade tensions put "on hold"

2018-05-21 reuters
TOKYO, May 21 (Reuters) - Japan’s Nikkei share average rose on Monday morning as exporters were boosted by a rise in the dollar rise against the yen.

 
This $2 Billion AI Startup Aims to Teach Factory Robots to Think - Bloomberg

2018-05-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
IBM selects Keio to host first quantum computing hub in Asia

2018-05-17 japantimes.co.jp
Keio University opened a research hub Thursday that can access IBM Corp.’s cutting-edge quantum computer system through the internet, with the aim of studying the possibilities of harnessing quantum computing.

 
Sumitomo Mitsui Signals It May Curb Coal-Fired Power Financing - Bloomberg

2018-05-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Regional banks fight for inheritance to ensure their survival

2018-05-15 japantimes.co.jp
Where there’s a will, there’s a way. That’s what banks across Japan are counting on as they try to keep hold of the ¥50 trillion in wealth left by their customers each year when they die.

 
Nikkei drops in choppy trade; Toshiba up on chip unit sale

2018-05-15 reuters
TOKYO, May 15 (Reuters) - Japanese stocks pulled back from a recent 3-1/2 month high on Tuesday, hit by profit-taking, though bank shares staged a rally on hopes of strong earnings for the sector.

 
Nikkei eases in choppy trade; banks rise on earnings hopes

2018-05-15 thehindubusinessline
Japanese stocks pulled back from 3-1-/2-month highs on Tuesday morning, though bank shares staged a rally on hopes of strong earnings for the sector.

 
Nikkei eases in choppy trade; banks rise on earnings hopes

2018-05-15 reuters
TOKYO, May 15 (Reuters) - Japanese stocks pulled back from 3-1-/2-month highs on Tuesday morning, though bank shares staged a rally on hopes of strong earnings for the sector.

 
Japan’s Banks Want to Keep Hold of Dead Customers’ Savings - Bloomberg

2018-05-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Asia markets: Oil, stocks, currencies and China data in focus

2018-05-15 cnbc
Asian shares looked set for a mixed start on Tuesday after U.S. stock indexes recorded gains amid an improvement in sentiment over U.S.-China trade developments.

 
Total net profit at Japan’s three mega-bank groups likely to grow for first time in four years

2018-05-08 japantimes.co.jp
The total net profit for Japan’s three mega-bank groups are believed to have grown year on year for the first time in four years in the fiscal year that ended in March.

 
Nikkei rises as banks rally; Takeda up ahead of acquisition news

2018-05-08 reuters
TOKYO, May 8 (Reuters) - Japan’s Nikkei share average rose on Tuesday as banking stocks rallied while Takeda Pharmaceutical climbed ahead of news the drugmaker had agreed to buy London-listed Shire for $62.42 billion.

 
Tech stocks, banks, Takeda’s Shire offer push Nikkei up

2018-05-08 thehindubusinessline
Japan's Nikkei share average rose on Tuesday as tech shares rallied and Takeda Pharmaceutical jumped after a report the drugmaker will make a formal offer to buy Shire for $62 billion.

 
Nikkei rises, helped by tech stocks, banks, Takeda's Shire offer

2018-05-08 reuters
TOKYO, May 8 (Reuters) - Japan’s Nikkei share average rose on Tuesday as tech shares rallied and Takeda Pharmaceutical jumped after a report the drugmaker will make a formal offer to buy Shire for $62 billion.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...